Abstract: An application of hyaluronic acid in preparing medicines for preventing or treating ferroptosis-related diseases is provided, and an application of hyaluronic acid or salts of hyaluronic acid or derivatives of hyaluronic acid in preparing medicines for inhibiting ferroptosis is also provided. According to the present application, the anti-ferroptosis function of hyaluronic acid is disclosed. The hyaluronic acid is the first natural extracellular matrix material with anti-ferroptosis function found at present. The hyaluronic acid is one of the components of natural extracellular matrix and exists in large quantities in human body and is also a widely used material in clinic.

Abstract: A fusion imaging gene and lentiviral expression plasmid, lentivirus and cell, and preparation methods and applications thereof are provided. The fusion imaging gene includes bioluminescence imaging gene, fluorescent protein gene and calcium imaging gene. The three genes are linked by linkers. The fusion gene is inserted into a modified lentiviral expression plasmid to obtain lentivirus particles carrying the fusion imaging gene.

Abstract: A fusion imaging gene and lentiviral expression plasmid, lentivirus and cell, and preparation methods and applications thereof are provided. The fusion imaging gene includes bioluminescence imaging gene, fluorescent protein gene and calcium imaging gene. The three genes are linked by linkers. The fusion gene is inserted into a modified lentiviral expression plasmid to obtain lentivirus particles carrying the fusion imaging gene.

Abstract: An application of hyaluronic acid in preparing medicines for preventing or treating ferroptosis-related diseases is provided, and an application of hyaluronic acid or salts of hyaluronic acid or derivatives of hyaluronic acid in preparing medicines for inhibiting ferroptosis is also provided. According to the present application, the anti-ferroptosis function of hyaluronic acid is disclosed. The hyaluronic acid is the first natural extracellular matrix material with anti-ferroptosis function found at present. The hyaluronic acid is one of the components of natural extracellular matrix and exists in large quantities in human body and is also a widely used material in clinic.

Abstract: A first processing device may receive, from a first network device, a tunneling protocol message associated with a tunnel to be established between the first network device and a second network device. The first processing device may determine, based on the tunneling protocol message, a device identifier of the second network device. The first processing device may determine that a second processing device is to process a flow associated with the first network device and the second network device based on the device identifier of the second network device. The first processing device may provide information that identifies that the second processing device is to process the flow to permit the second processing device to process the flow associated with the first network device and the second network device.

Abstract: A network device having multiple service units receives an outbound packet of a communication session, where the service units can perform network address translation (NAT) on the outbound packet. The outbound packet includes a private source network address and source port. The network device applies a service unit selection function to a header of the outbound packet to produce a first result, and selects, based on the first result, a service unit to perform NAT for packets of the communication session. The network device determines a port for network address translation that produces a second result equal to the first result when the service unit selection function is applied to the portion of the header when the portion includes a selected public network address and determined port. The service unit can thereby perform session-aware services on packets of the communication session without redirecting the packets between the service units.

Abstract: The present invention provides methods for treating or reducing neurologic and ischemic vascular disorders.